New Players in Life Science Innovation, The: Best Practices in R&D from Around the World The, Safari

This is the Safari online edition of the printed book.

In The New Players in Life Science Innovation, Tomasz Mroczkowski explains how emerging economies and companies are rapidly achieving leadership in the global biosciences industries, and thoroughly assesses the implications. Mroczkowski discusses the sophisticated innovation strategies and reforms nations like China and India have implemented, including strategies that complement markets with aggressive state intervention. He previews the emerging global "bio-economy," in which life science discoveries will be applied pervasively in markets ranging from health to fuels. As R&D in the West becomes increasingly costly, he introduces new options for partnering with new players in the field, beginning with globalized clinical trials and contract research. Offering examples from China to Dubai to India, he carefully assesses the business models driving today's newest centers of innovation, offering up-to-date coverage of bioparks, technology zones, emerging clusters, and other approaches. He also presents realistic assessments of global R&D collaboration strategies such as those of Eli Lilly, Merck, Novartis, and IBM, including both operational and long-term strategic challenges. The New Players in Life Science Innovation will be an indispensable resource for every R&D decision-maker, investor, and business leader in the life sciences, and in many industries with deepening links to the biosciences, such as information technology and energy.

Acknowledgments     viii

About the Author     ix

Chapter 1 Power Shifts in Global R&D and Innovation: What They Mean for Firms in Life Science Businesses     1

Chapter 2 The Race for the Best National Innovation System: Who Has the Most Effective Strategy     37

Chapter 3 A Reshuffling of Markets and Growth Opportunities     73

Chapter 4 Improving R&D Productivity: Contract Research and Discovery Collaborations with the New Players as Solutions     109

Chapter 5 Globalization of Clinical Trials: It Is Not Just About Slashing Costs     151

Chapter 6 Accelerating Innovation: Bioparks, Technology Zones, and Emerging Clusters     193

Chapter 7 Company Strategies of Global R&D Collaborations: From West Meets West to West Meets East     229

Chapter 8 The Future: The Expanding Universe of Global Innovation     269

Endnotes     303

Index     331